ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,387, issued on March 25, was assigned to FIBROSYS S.R.L. (Baronissi, Italy).
"Anti-BAG3 antibodies as therapeutic reagent in cardiovascular disease" was invented by Maria Caterina Turco (Avellino, Italy), Liberato Marzullo (Scalea, Italy), Alessandra Rosati (Baronissi, Italy), Margot De Marco (Salerno, Italy) and Anna Basile (Bracigliano, Italy).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of anti-BAG3 antibodies and its pharmaceutical formulation in the treatment of cardiovascular diseases."
The patent was filed on March 24, 2022, under Application No. 17/703,747.
*For further information, including imag...